Award
National Institute of Neurological Disorders and Stroke 5R42NS098918-05
A Novel Xenon Delivery Platform for Cerebroprotection During Stroke
Recipient
ZYMO RESEARCH CORPORATION
Award Amount
$980,725.00
Ceiling
$980,725.00
Awarded
August 06, 2025
Identifier
5R42NS098918-05
Award for developing a Xenon-Liposome delivery platform to protect the brain during stroke, focusing on translational research and clinical trials.
Description
This project explores a novel approach to stroke treatment involving intermittent administration of Xenon-Liposome (XKS07) for acute ischemic stroke. The research aims to develop this formulation through IND-enabling studies, FDA pre-IND discussion, and proceed to IND application, including Phase I and II clinical trials. The project is managed by Zymo Research Corporation in partnership with UTHealth and other consultants.